UDG Healthcare is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing over 9,000 people with operations in 24 countries and delivering services in over 50 countries.
UDG Healthcare plc operates across three divisions: Ashfield, Sharp and Aquilant.
Ashfield is a global leader in advisory, communication, commercial and clinical services. Ashfield helps improve lives by supporting well-informed conversations with healthcare professionals, payers and patients.
Ashfield is the largest division of UDG Healthcare by profit contribution, and has grown rapidly over recent years. Ashfield focuses on supporting healthcare professionals and patients at all stages of the product life cycle. As a global leader in commercialisation services, Ashfield works with global pharmaceutical and healthcare clients, providing multi-channel communication strategies, sales, marketing, patient engagement and medical services.
Sharp is a global leader in contract packaging and clinical trial supply chain solutions services. Sharp has over1,800 employees, working from nine different locations, with a shared vision of delivering world-class services in clinical trial, commercial packaging, design and technology services for our global pharma clients.
A leading expert and provider of outsourced services to the medical and scientific sector. Aquilant’s services include medical and scientific device sales, marketing, engineering and distribution in areas such as endoscopy, cardiology, radiology, surgical and orthopaedics. It operates within the Republic of Ireland, the UK and the Netherlands to orchestrate appropriate solutions for clients, purchasers, clinicians and patients.
The company is listed on the London Stock Exchange and is a constituent of the FTSE 250.
- Top 30 pharma companies are all customers
- $1,028.15 million 2017 net revenue
- $129.3 million 2017 operating profit
- 30+ years dividend growth
09 April 2018
RT @Sharp_Services: We are now over halfway through our expansion project at Sharp Bethlehem! The plans for our new Formulation Lab are ful…
- 07 April 2018
- 06 April 2018